Skip to content

Postponement of Curexa Pharmacy project

By

In May 2024, QleanAir announced a cleanroom agreement with Curexa Pharmacy, with an order value of USD 2 500 000, which was planned for completion during 2024. QleanAir has today recived information from Curexa Pharmacy that they postpone the project. At this time, QleanAir do not know what this means in time or possible extent. QleanAir sees … Continued

Invitation to the presentation of the second quarter report 2024

By

QleanAir invites to teleconference and audio cast on August 9th, at 10.00 am CEST. The company’s CEO, Sebastian Lindström, and CFO, Henrik Resmark, present the interim report for the second quarter 2024 in English. The presentation will start at 10 am and can be joined via the web or by telephone. It will be available … Continued

Curexa Pharmacy a leading provider of specialty compounding services in Egg Harbor Township, NJ has signed an agreement with QleanAir Scandinavia Inc.

By

The agreement is for a 503(A) cleanroom suite for their new location in Gilbert, Arizona. QleanAir AB (publ), the premium provider of clean indoor environment solutions, announces an order for a new QleanSpace cleanroom from Curexa Pharmacy. The agreement value is projected at approximately USD $2,500,000. The new cleanroom suite is expected to be completed … Continued

Annual general meeting held in QleanAir AB

By

Today, the annual general meeting of 2024 was held in QleanAir AB (the “Company” or “QleanAir”). Below follows a summary of the resolutions passed at the annual general meeting. The annual general meeting resolved (in accordance with the proposals presented in the notice to attend the meeting kept available at the Company’s website www.qleanair.com): to … Continued

QLEANAIR INTERIM REPORT Q1 2024 – STABLE REVENUE AND OPERATING MARGIN

By

"We had a stable financial performance in the first quarter, with currency-adjusted growth of almost 3%. The weakening of the Japanese yen affected our revenue negatively by 6 MSEK. Sequentially, we improved the operating margin to 9.7% compared to 7.8% in the fourth quarter 2023. We have not reached our goal yet, but we are … Continued